Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Future Chemotherapy Could Target Tumor Cell Social Interactions

By BiotechDaily International staff writers
Posted on 11 Oct 2012
Collections of cancer cells - tumors- display many characteristics of communal communication and social interaction that typify collections of bacterial cells, and an international team of theoretical biologists have suggested that development of new cancer treatments should be based on attacking tumors at the level of these social interactions.

Investigators at Rice University (Houston, TX, USA), Johns Hopkins University (Baltimore, MD, USA), and Tel Aviv University (Israel) suggested in a paper published in the September 2012 issue of the journal Trends in Microbiology that the communal behavior of bacteria represent a valuable model system for new perspectives and research directions in cancer chemotherapy. As an example they site the behavior of some types of cancer that revert to a dormant, unresponsive state when challenged by drug treatment. Absence of the drug stimulates a signaling process that reawakens the tumor.

“Cancer is a sophisticated enemy. There is growing evidence that cancer cells use advanced communications to work together to enslave normal cells, create metastases, resist drugs, and decoy the body’s immune system,” said first author Dr. Eshel Ben-Jacob, professor of physics at Tel Aviv University. “If we can break the communication code, we may be able to prevent the cells from going dormant or to reawaken them for a well-timed chemotherapeutic attack. This is just one example. Our extensive studies of the social lives of bacteria suggest a number of others, including sending signals that trigger the cancer cells to turn upon themselves and kill one another.”

Related Links:

Rice University
Johns Hopkins University
Tel Aviv University



SLAS - Society for Laboratory Automation and Screening
RANDOX LABORATORIES
BIOSIGMA S.R.L.
comments powered by Disqus

Channels

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Lab Technologies

view channel
Image: On target: When researchers introduced nanobodies they made to cells engineered to express a tagged version of a protein in skeletal fibers known as tubulin (red), the nanobodies latched on. The cells above have recently divided (Photo courtesy of Rockefeller University).

Turning Antibodies into Precisely Tuned Nanobodies

New technology has the potential to create nanobodies making them much more accessible than antibodies for all sorts of research. Antibodies control the process of recognizing and zooming in on molecular... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.